Antje Wick

机构：Heidelberg University, University Hospital Heidelberg · ORCID：0000-0003-0020-6386

发表论文 286 篇 · 总被引 12864 次 · h-index 50

代表论文

• The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant (2025 · Neuro-Oncology · 被引 17)
• Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial (2025 · Nature Medicine · 被引 13)
• IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial (2026 · Nature Cancer · 被引 3)
• Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profiles (2025 · Neuro-Oncology · 被引 3)
• Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial (2026 · Nature Cancer · 被引 2)
• CTIM-08. FIRST IN HUMAN STUDY OF THE MRNA-BASED CANCER VACCINE CVGBM IN PATIENTS (PTS) WITH NEWLY-DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA (GBM): FIRST RESULTS FROM THE DOSE ESCALATION PHASE (2024 · Neuro-Oncology · 被引 2)